• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Hopkins Deborah C

    6/3/26 4:20:08 PM ET
    $MRSH
    Specialty Insurers
    Finance
    Get the next $MRSH alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    HOPKINS DEBORAH C

    (Last)(First)(Middle)
    C/O MARSH & MCLENNAN COMPANIES, INC.
    1166 AVENUE OF THE AMERICAS

    (Street)
    NEW YORK NEW YORK 10036

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    06/01/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Restricted Stk. Units-Dir. Stk. Plan(1)06/01/2026A(2)1,349.82 (3) (3)Common Stock1,349.82$159.2821,414.56D
    Explanation of Responses:
    1. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.
    2. Annual stock award of 1,349.82 shares pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.
    3. Not Applicable
    /s/ Tessa Patti, Attorney-in-fact06/03/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $MRSH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MRSH

    DatePrice TargetRatingAnalyst
    5/6/2026$200.00Neutral → Buy
    Citigroup
    2/27/2026$199.00Outperform → Neutral
    Mizuho
    2/17/2026$225.00Outperform → Strong Buy
    Raymond James
    More analyst ratings

    $MRSH
    SEC Filings

    View All

    SEC Form 10-Q filed by Marsh

    10-Q - MARSH & MCLENNAN COMPANIES, INC. (0000062709) (Filer)

    7/21/26 8:13:36 AM ET
    $MRSH
    Specialty Insurers
    Finance

    Marsh filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MARSH & MCLENNAN COMPANIES, INC. (0000062709) (Filer)

    7/21/26 7:02:42 AM ET
    $MRSH
    Specialty Insurers
    Finance

    SEC Form 11-K filed by Marsh

    11-K - MARSH & MCLENNAN COMPANIES, INC. (0000062709) (Filer)

    6/22/26 4:57:04 PM ET
    $MRSH
    Specialty Insurers
    Finance

    $MRSH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Doyle John Q exercised 16,656 shares at a strike of $73.19 and sold $2,693,442 worth of shares (16,656 units at $161.71) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 116,811 units (SEC Form 4)

    4 - MARSH & MCLENNAN COMPANIES, INC. (0000062709) (Issuer)

    6/3/26 4:33:43 PM ET
    $MRSH
    Specialty Insurers
    Finance

    SEC Form 4 filed by Director Schapiro Morton O

    4 - MARSH & MCLENNAN COMPANIES, INC. (0000062709) (Issuer)

    6/3/26 4:23:47 PM ET
    $MRSH
    Specialty Insurers
    Finance

    SEC Form 4 filed by Director Anderson Anthony

    4 - MARSH & MCLENNAN COMPANIES, INC. (0000062709) (Issuer)

    6/3/26 4:22:43 PM ET
    $MRSH
    Specialty Insurers
    Finance

    $MRSH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Marsh Reports Second Quarter 2026 Results

    Revenue Growth of 6%; Underlying Revenue Growth of 5% GAAP Operating Income Increases 4%; Adjusted Operating Income Increases 5% Second Quarter GAAP EPS of $2.63; Adjusted EPS Increases 9% to $2.96 Six Months GAAP EPS of $4.99; Adjusted EPS Increases 8% to $6.25 Marsh (NYSE:MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today reported financial results for the second quarter ended June 30, 2026. John Doyle, President and CEO, said: "I am pleased with our solid results in the quarter and our execution in a dynamic environment. Our performance in the first half underscores strong demand for Marsh's expertise and capab

    7/21/26 7:00:00 AM ET
    $MRSH
    Specialty Insurers
    Finance

    Marsh Survey Reveals That Insurers’ Private Credit Appetite Continues to Grow, but Discipline Remains Paramount

    Marsh (NYSE:MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today released the findings of its 2026 Global Insurance Investments Survey, which shows that insurers’ demand for private credit remains strong but increasingly selective. More than half (57%) of the insurers surveyed plan to increase their exposure to private credit in the next 12 to 24 months, making it the leading area of planned investment growth, ahead of public investment-grade fixed income, which was cited by 48% of insurers. This is in sharp contrast to the Mercer and Oliver Wyman 2024 Global Insurance Investments Survey, when 37% and 32% of insurers planned to

    7/16/26 11:00:00 AM ET
    $MRSH
    Specialty Insurers
    Finance

    American Beacon and Mercer Launch Innovative Model Portfolio Solutions for Financial Intermediaries

    Collaboration pairs American Beacon’s distribution and fund management capabilities with Mercer’s global investment expertise to deliver diversified, risk managed model portfolios American Beacon Advisors, Inc. ("American Beacon"), an experienced provider of investment advisory services to institutional and retail markets, today announced the launch of the Mercer & American Beacon Model Portfolios, a suite of professionally managed investment solutions developed in collaboration with Mercer Investments LLC ("Mercer"), a Marsh business and one of the world’s largest investment consulting and management firms. The Mercer & American Beacon Model Portfolios combine thematic investing strate

    7/15/26 9:00:00 AM ET
    $MRSH
    Specialty Insurers
    Finance

    $MRSH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Marsh McLennan upgraded by Citigroup with a new price target

    Citigroup upgraded Marsh McLennan from Neutral to Buy and set a new price target of $200.00

    5/6/26 7:31:43 AM ET
    $MRSH
    Specialty Insurers
    Finance

    Marsh McLennan downgraded by Mizuho with a new price target

    Mizuho downgraded Marsh McLennan from Outperform to Neutral and set a new price target of $199.00

    2/27/26 8:29:19 AM ET
    $MRSH
    Specialty Insurers
    Finance

    Marsh McLennan upgraded by Raymond James with a new price target

    Raymond James upgraded Marsh McLennan from Outperform to Strong Buy and set a new price target of $225.00

    2/17/26 8:04:32 AM ET
    $MRSH
    Specialty Insurers
    Finance

    $MRSH
    Financials

    Live finance-specific insights

    View All

    Marsh Reports Second Quarter 2026 Results

    Revenue Growth of 6%; Underlying Revenue Growth of 5% GAAP Operating Income Increases 4%; Adjusted Operating Income Increases 5% Second Quarter GAAP EPS of $2.63; Adjusted EPS Increases 9% to $2.96 Six Months GAAP EPS of $4.99; Adjusted EPS Increases 8% to $6.25 Marsh (NYSE:MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today reported financial results for the second quarter ended June 30, 2026. John Doyle, President and CEO, said: "I am pleased with our solid results in the quarter and our execution in a dynamic environment. Our performance in the first half underscores strong demand for Marsh's expertise and capab

    7/21/26 7:00:00 AM ET
    $MRSH
    Specialty Insurers
    Finance

    Marsh Increases Quarterly Cash Dividend

    The Board of Directors of Marsh (NYSE:MRSH) today declared a 10% increase in the quarterly dividend from $0.900 to $0.990 per share on outstanding common stock, payable on August 14, 2026, to stockholders of record on July 23, 2026. About Marsh Marsh (NYSE:MRSH) is a global leader in risk, reinsurance and capital, people and investments, and management consulting, advising clients in 130 countries. With annual revenue of $27 billion and more than 95,000 colleagues, Marsh helps build the confidence to thrive through the power of perspective. For more information, visit corporate.marsh.com, or follow us on LinkedIn and X. View source version on businesswire.com: https://www.businesswire.co

    7/8/26 12:00:00 PM ET
    $MRSH
    Specialty Insurers
    Finance

    Marsh Reports Strong First Quarter 2026 Results

    Revenue Growth of 8%; Underlying Revenue Growth of 4% GAAP Operating Income Decreases 12%; Adjusted Operating Income Increases 8% First Quarter GAAP EPS of $2.36; Adjusted EPS Increases 8% to $3.29 Marsh (NYSE:MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today reported financial results for the first quarter ended March 31, 2026. John Doyle, President and CEO, said: "We had a solid start to the year, and I am pleased with our execution in a dynamic and challenging environment. For the quarter, we generated 8% overall revenue growth, 4% underlying revenue growth, 8% adjusted operating income growth, and 8% adjusted EP

    4/16/26 7:00:00 AM ET
    $MRSH
    Specialty Insurers
    Finance

    $MRSH
    Leadership Updates

    Live Leadership Updates

    View All

    Andrew Bainbridge named General Counsel & Chief Compliance Officer of Oliver Wyman and Marsh Management Consulting

    Oliver Wyman, a global leader in management consulting and a business of Marsh (NYSE:MRSH), today announced the appointment of Andrew Bainbridge as General Counsel & Chief Compliance Officer. Since joining the company in 2011, Andrew has held a series of senior leadership positions within its Legal, Compliance, and Public Affairs organization. Most recently, he served as Deputy General Counsel for Oliver Wyman and Marsh Management Consulting, where he oversaw legal and compliance matters across Europe, India, the Middle East and Africa, and the Asia-Pacific region. Prior to joining Marsh, Andrew practiced as an M&A lawyer at Bryan Cave Leighton Paisner in London and held in-house legal ro

    6/1/26 10:17:00 AM ET
    $MRSH
    Specialty Insurers
    Finance

    Marsh Appoints Mark McGivney as Executive Vice President and Chief Operating Officer in Addition to Chief Financial Officer

    Marsh (NYSE:MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today announced that Mark McGivney, Marsh's Chief Financial Officer, will assume additional roles as Executive Vice President and Chief Operating Officer of the firm. These changes are effective April 15. Commenting on the appointment, Marsh CEO John Doyle said, "Mark has been instrumental in the success and performance of Marsh for nearly 20 years. As CFO, he supported the design and execution of our strategy, and in his expanded role, he will help drive forward company priorities at an even greater pace and scale in a complex macroenvironment. I look forward to his con

    4/14/26 8:15:00 AM ET
    $MRSH
    Specialty Insurers
    Finance

    Marsh Appoints Ted Moynihan President and CEO of Marsh Management Consulting and Oliver Wyman

    Marsh (NYSE:MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today announced Ted Moynihan will become President and CEO of Marsh Management Consulting and Oliver Wyman, succeeding Nick Studer, who has been appointed President and CEO of Marsh Risk. Mr. Moynihan will serve on the company's Executive Committee and report to John Doyle, President and CEO of Marsh. Mr. Moynihan's appointment is effective tomorrow, and he will continue to be based in London. Commenting on the appointment, Mr. Doyle said, "Ted brings extensive leadership experience and a proven track record of driving transformation and growth in the consulting sector.

    3/31/26 7:30:00 AM ET
    $MRSH
    Specialty Insurers
    Finance